The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings

- Abdullah, Noraidatulakma, Attia, John, Oldmeadow, Christopher, Scott, Rodney J., Holliday, Elizabeth G.

Differing contributions of classical risk factors to type 2 diabetes in multi-ethnic Malaysian populations

- Abdullah, Noraidatulakma, Murad, Nor Azian Abdul, Attia, John, Oldmeadow, Christopher, Kamaruddin, Mohd Arman, Jalal, Nazihah Abd, Ismail, Norliza, Jamal, Rahman, Scott, Rodney J., Holliday, Elizabeth G.

Direct integrin αvβ6-ERK binding: implications for tumour growth

- Ahmed, Nuzhat, Niu, Jun, Dorahy, Douglas J., Gu, Xinhua, Andrews, Sarah, Meldrum, Cliff J., Scott, Rodney J., Baker, Mark S., Macreadie, Ian G., Agrez, Michael V.

Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk

- Ashton, Katie, Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, McEvoy, Mark, Attia, John, Gilbert, Michael, Hamann, Ute, Scott, Rodney J.

Genetic variants in MUTYH are not associated with endometrial cancer risk

- Ashton, Katie A., Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, Scott, Rodney J.

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer

- Ashton, Katie A., Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, McEvoy, Mark, Attia, John, Gilbert, Michael, Hamann, Ute, Scott, Rodney J.

Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk

- Ashton, Katie A., Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, McEvoy, Mark, Attia, John, Scott, Rodney J.

The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor

- Ashton, Katie A., Proietto, Anthony, Otton, Geoffrey, Symonds, Ian, McEvoy, Mark, Attia, John, Gilbert, Michael, Hamann, Ute, Scott, Rodney J.

Frequency of the common MYH mutations (G382D and Y165C) in MMR mutation positive and negative HNPCC patients

- Ashton, Katie A., Kairupan, C. F., Scott, Rodney J., Meldrum, C. J., McPhillips, M. L.

How to use an article about genetic association. A: background concepts

- Attia, John, Ioannidis, John P. A., Thakkinstian, Ammarin, McEvoy, Mark, Scott, Rodney J., Minelli, Cosetta, Thompson, John, Infante-Rivard, Claire, Guyatt, Gordon

How to use an article about genetic association. B: are the results of the study valid?

- Attia, John, Ioannidis, John P. A., Thakkinstian, Ammarin, McEvoy, Mark, Scott, Rodney J., Minelli, Cosetta, Thompson, John, Infante-Rivard, Claire, Guyatt, Gordon

How to use an article about genetic association. C: what are the results and will they help me in caring for my patients?

- Attia, John, Ioannidis, John P. A., Thakkinstian, Ammarin, McEvoy, Mark, Scott, Rodney J., Minelli, Cosetta, Thompson, John, Infante-Rivard, Claire, Guyatt, Gordon

Detecting genotyping error using measures of degree of Hardy-Weinberg disequilibrium

- Attia, John, Thakkinstian, Ammarin, McElduff, Patrick, Milne, Elizabeth, Dawson, Somer, Scott, Rodney J., de Klerk, Nicholas, Armstrong, Bruce, Thompson, John

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

- Avery-Kiejda, Kelly A., Braye, Stephen G., Forbes, John F., Scott, Rodney J.

Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin

- Avery-Kiejda, Kelly A., Zhang, Xu Dong, Adams, Luke J., Scott, Rodney J., Vojtesek, Borivoj, Lane, David P., Hersey, Peter

The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.

- Avery-Kiejda, Kelly A., Morten, Brianna, Wong-Brown, Michelle W., Mathe, Andrea, Scott, Rodney J.

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer

- Avery-Kiejda, Kelly A., Braye, Stephen G., Mathe, Andrea, Forbes, John F., Scott, Rodney J.

Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases

- Avery-Kiejda, Kelly A., Mathe, Andrea, Scott, Rodney J.

Genetic markers in breast cancer - how far have we come from BRCA1?

- Avery-Kiejda, Kelly A., Wong, Michelle W., Scott, Rodney J.

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

- Avery-Kiejda, Kelly A., Bowden, Nikola A., Hersey, Peter, Croft, Amanda J., Scurr, Lyndee L., Kairupan, Carla F., Ashton, Katie A., Talseth-Palmer, Bente A., Rizos, Helen, Zhang, Xu D., Scott, Rodney J.